via lifescience.com
Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.
Delivering cancer drugs directly to tumors is difficult. Scientists are working on new approaches to overcome the natural limitations of drugs, including loading them into nanoparticles.
“The drug is packaged into a lipid ball significantly smaller than the width of a hair to make it soluble in the blood stream and prevent negative side effects. The drug-containing nanoparticle ball then travels in the bloodstream to the tumor, where it accumulates and the drug is released in the tumor to kill the cancer cells,” said Gavin Robertson, professor of pharmacology, pathology, dermatology, and surgery and director of the Penn State Hershey Melanoma Center.
In previous research, Robertson discovered the cancer-fighting characteristics of leelamine, a substance derived from pine bark. But leelamine cannot be given by mouth because of poor uptake in the gastrointestinal tract or be injected intravenously because it causes damage to red blood cells.
To address this issue, Robertson and his team developed a new nanoliposome that loads leelamine, called Nanolipolee-007. Nanolipolee-007 can be injected intravenously without causing damage to red blood cells. It then accumulates in tumors because of its small size where it releases the drug to kill the cancer cells.
Leelamine is the first of a new unique class of drugs that inhibits cholesterol movement around a cancer cell to shut down signals needed for cancer cell survival. As a result, protein pathways like the PI3K, MAPK and STAT3 that are highly active and help cancer cells multiply and spread, are turned off and the cancer cells die. Since normal cells are not addicted to the high levels of activity of these pathways that occur in cancer cells, the drug has a minor effect on them.
“This nanoparticle moves leelamine one step closer to the clinic,” Robertson said. “We now have a drug that has the potential to be given to humans that could not be done before.”
The researchers showed the results of Nanolipolee-007 on cells growing in culture dishes and in tumors growing in mice following intravenous injection. Leelamine inhibited tumor development in mice with no detectable side effects.
The Latest on: Drug-containing nanoparticle
[google_news title=”” keyword=”drug-containing nanoparticle” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug-containing nanoparticle
- A laser-based method for measuring particle size distribution during the grinding processon July 24, 2024 at 1:25 pm
How pharmaceuticals act, how efficient catalysts are and how effective and accurate printing inks function all depend on the size of the nanoparticles they contain. However, there are as of yet no ...
- ChemoRad Nanoparticles: A Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiationon July 14, 2024 at 5:00 pm
In this study, we report the development of a novel NP (nanoparticle ... size, stability, drug release profile and radioisotope chelation properties of the ChemoRad NP, followed by evaluating ...
- 60 years in the making: Nanoparticles revolutionize nucleotide deliveryon July 9, 2024 at 11:16 pm
Researchers trace the 60-year evolution of lipid nanoparticles (LNPs) for nucleic acid delivery, highlighting their potential to revolutionize gene therapy with safer and more effective treatments.
- How are Nanoparticles Used for Drug Delivery?on July 3, 2024 at 5:00 pm
2 Recent advances in nanotechnology have shown that nanoparticles (NPs)—particles smaller than 100 nm in at least one dimension—are promising drug carriers. NPs provide innovative ways for targeted ...
- Novel peptide formulation shows promise of restoring cognitive decline in schizophreniaon June 26, 2024 at 5:01 pm
Nanoparticle-based drug delivery systems (DDS) containing peptides offer an innovative approach to effectively treat schizophrenia. Such DDSs hold significant potential to revolutionize ...
- Intriguing new tool for tendon healing: nanoparticles for precision drug deliveryon June 26, 2024 at 5:01 pm
Harnessing nanoparticles to deliver drugs precisely to a surgically repaired tendon is a promising new approach that reduced scar tissue formation and improved mechanical function. Harnessing ...
- Curcumin nanoparticles show promise in treating neurodegenerative diseaseson June 6, 2024 at 8:59 pm
In a review article published in the journal Foods, researchers in Italy have illustrated the neuroprotective role of curcumin and curcumin-containing nanoparticles in neurodegenerative diseases.
- Nanoprecipitation: A Versatile Method for Nanoparticle Synthesison April 13, 2024 at 9:35 am
Diagram illustrating the nanoprecipitation process for creating polymeric nanoparticles: An organic solution containing a polymer and a drug is added to an aqueous solution with surfactant. Through ...
- The emerging nanomedicine landscapeon September 13, 2020 at 6:20 am
FDA regulates products on a product-by-product basis and up to now the FDA has not required special testing of products containing nanoparticles. Examples of already approved drugs with particles ...
- Nanoparticles Types, Properties and Useson April 3, 2019 at 9:28 am
Liquid-phase eutectic gallium–indium (EGaIn) alloy nanoparticles. Lipids – These NPs contain lipid moieties and are used in many biomedical applications as drug carriers (the mRNA Covid-19 vaccines ...
via Bing News
